Dr Surulivel Rajan M
Professor & Head
12.09.2005
Department of Pharmacy Practice
CURRENT ACADEMIC ROLE & RESPONSIBILITIES
- Staff Coordinator for fifth Year Pharm.D program
- Approved PhD guide
- Guide for M.Pharm dissertation work and Pharm.D project
- Coordinator of Department Research Committee (DRC)
- Coordinator of Centre for Pharmacometrics
Dr. M Surulivelrajan completed post-doctoral fellowship at University of North Texas System College of Pharmacy, USA. He is working in the area of Pharmacometrics to develop models for drug pharmacokinetics and pharmacodynamics to develop medication compliance model. He has following roles and responsibilities:
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| Post-doctoral Fellowship | Pharmacometrics | University of North Texas System College of Pharmacy | 2018 |
| PhD (Doctor of Philosophy) | Population Pharmacokinetics | Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education | 2011 |
| Post Graduate Diploma in Clinical Research | Clinical Research | Institute of Clinical Research, New Delhi | 2004 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| Department of Pharmacy Practice, MCOPS Manipal | Professor | 2022-onwards | |
| Department of Pharmacy Practice, MCOPS Manipal | Associate Professor | ||
| Department of Pharmacy Practice, MCOPS Manipal | Assistant Professor – Selection Grade | 2012 | |
| Department of Pharmacy Practice, MCOPS Manipal | Assistant Professor | 2011 | |
| Department of Pharmacy Practice, MCOPS Manipal | Senior Lecturer | 2007 | |
| Department of Pharmacy Practice, MCOPS Manipal | Lecturer | 2005 | |
| PSG College of Pharmacy, Coimbatore | Lecturer | Taught undergraduate students and providing clinical pharmacy services to the affiliated hospital. | 2004-2005 |
| Sri Ramachandra College of Pharmacy, Chennai | Lecturer | Taught undergraduate students and providing clinical pharmacy services to the affiliated hospital. | 2001-2003 |
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Clinical Pharmacy
Area of Expertise
Population Pharmacokinetic Models
Area of Research
Pharmacometrics, Clinical Services of Pharmacists
Professional Affiliations & Contributions
- Founder Member of KSPOR, 2010.
- Founder Member of ACPI, 2007.
- Life Member of IHPA, 2008.
Work Experience
| Organisation | Role | Tenure |
|---|---|---|
| USV Limited, Mumbai | Business Development Executive Worked in the assessment of product portfolio and involved in both the scientific and market assessment of the products to be launched |
Population pharmacokinetics of lamotrigine in Indian epileptic patients
2013-01-01 Martin G Johnson Thiyagu Rajakannan Padma GM Rao Lokesh Bathala
European Journal of Clinical pharmacology, 2013, 69(1):43-52.
Cost of adverse reactions in a South Indian tertiary care teaching hospital
2012-01-01 Thiyagu Rajakannan Vasudeva Guddattu Asha Kamath Rajesh V
Journal of Clinical Pharmacology, 2012, 52:559-565.
Development and validation of an instrument to assess the perception of pharmacy students on medication review process
2012-01-01 Rao JR Sravanthi LK Rajat TS
Indian Journal of Pharmacy practice, 2012, 5(3):69-74.
Pattern of angiotensin - converting enzyme inhibitors induced adverse drug reactions in South Indian teaching hospital
2012-01-01 Uday Venkat Mateti Haritha Nekkanti Rajesh V Thiyagu Rajakannan
North American Journal of Medical Sciences. 2012, 4(4):185-9.
High performance liquid chromatographic fluorescence detection method for the quantification of rivastigmine in rat plasma and brain - Application to preclinical pharmacokinetic studies in rats
2011-01-01 Arumugam K Chamallamudi MR Mullangi R Ganesan S
Journal of Young Pharmacists. 2011, 3(4):315-321.
Potential drug interactions in patients admitted to cardiology wards of a South Indian teaching hospital
2011-01-01 Virendra K P Leelavathi D Acharya Thiyagu R Vasudeva G
Australasian Medical Journal AMJ 2011, 4, 1, 9-14.
Drug-drug interactions in hospitalized hospitalised cardiac patients
2011-01-01 Mateti UV Rajakannan T Nekkanti H Rajesh V
J Young Pharm, 2011, 3(4): 329-333.
A sensitive and selective HPLC method for estimation of lamotrigine in human plasma and saliva - application to plasma-saliva correlation in epileptic patients
2010-01-01 Karthik Arumugam Tarun jain Thiyagu R Krishnamurthy B
Arzeimittel Forschung, 2010, 60(10); 599-606.
Study of tissue and the plasma concentrations of cefotaxime to assess its suitability for prophylaxis in cholecystectomy
2010-01-01 Leelavathi D Acharya Suresh S Anand Rao Sohil Ahmed Khan
Journal of Clinical and Diagnostic researchResearch, 2010, 4:2410-2415.
Development of indicators for identifying adverse drug events in an Indian tertiary care teaching hospital
Rajakannan Thiyagu Rajesh V Smitha Prabhu Sudha Vidyasagar
Drug, Health care Care and patient Patient safetySafety, 2010, 2:95-100 .
Video assisted patient education improves compliance with follow up and depression scores in Inflammatory Bowel Diseases.
Kamat N Rajan Mallayasamy S Sharma PSVN Kamath A Pai CG
Postgraduate Medicine, 2018;130(3):355-360.
Direct costs for nonsurgical management of Chronic Pancreatitis in a tertiary care teaching hospital.
Kamat N Pai G Mallayasamy SR Kamath A S R
Expert Review of Pharmacoeconomics and Outcomes Research, 2018;18(3):315-320.
Cost of Illness in Inflammatory Bowel Disease.
Kamat N Ganesh Pai C Surulivel Rajan M Kamath A.
Digestive Diseases and Science, 2017;62(9):2318-2326.
Assessment of cost of illness for diabetic patients in South Indian tertiary care hospital.
Acharya LD Rau NR Udupa N Rajan MS Vijayanarayana K
Journal of Pharmacy and Bioallied Sciences, 2016;8(4):314-320.
Full Publications list
Therapeutic drug monitoring of Lamotrigine in Plasma and Saliva
2007-01-01 Abhishek Pradhan
2007, PG This project involved the study of drug level monitoring of lamotrigine in plasma and saliva.
Development of dosage regimen for valproate using Population pharmacokinetic simulations
2012-01-01 Shivsagar
2012.This project involved the use of complex NONMEM software for the development of pharmacokinetic simulations.